Revised Myeloma Comorbidity Index
myelomacomorbidityindex.orgThe Revised Myeloma Comorbidity Index (R-MCI) is a clinical risk assessment tool designed to estimate prognosis and therapy-associated risks for patients with multiple myeloma. It calculates a weighted score based on six key factors: age, estimated glomerular filtration rate, Karnofsky Performance Status, cytogenetics, frailty, and lung function. The resulting score stratifies patients into low, intermediate, or high-risk prognostic groups to guide treatment decisions.
LLM mention score The LLM mention score is the total number of mentions of this brand in different LLM chatbots, normalized to the scale from 0 to 100. You can get actual, non-normalized numbers via the LLM Mention API from DataForSEO.
Normalized 0–100 · last 8 weeks
DataForSEO API
Get LLM mention data of any company via DataForSEO API
Get access to the structured data on keyword, brand, and website mentions in LLMs, including metrics like AI search volume, impressions, and mentions count.
How to get LLM mention data →// Fetch Revised Myeloma Comorbidity Index mentions POST v3/ai_optimization/llm_mentions/search_mentions/live [ { "target": [ { "domain": "myelomacomorbidityindex.org", "search_filter": "include", "search_scope": ["sources"] } ], "order_by": ["ai_search_volume,desc"] } ]
